This is not the latest version of this item. The latest version can be found here.
Discovery of 2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one derivatives as possible antileishmanial agents
Seth, A. Ghoshal, A. Dewaker, V. Rani, A. Singh, S.P. Dutta, M. Katiyar, S. Singh, S.K. Rashid, M. Wahajuddin, Muhammad
Seth, A.
Ghoshal, A.
Dewaker, V.
Rani, A.
Singh, S.P.
Dutta, M.
Katiyar, S.
Singh, S.K.
Rashid, M.
Wahajuddin, Muhammad
Publication Date
2022-06
End of Embargo
Supervisor
Rights
Peer-Reviewed
Yes
Open Access status
closedAccess
Accepted for publication
2022-05-22
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
A series of uniquely functionalized 2,3,-dihydro-1H-pyyrolo[3,4-b]quinolin-1-one derivatives were synthesized in one to two steps by utilizing a post-Ugi modification strategy and were evaluated for antileishmanial efficacy against visceral leishmaniasis (VL). Among the library compounds, compound 5m exhibited potential in vitro antileishmanial activity (CC50 = 65.11 μM, SI = 7.79, anti-amastigote IC50 = 8.36 μM). In vivo antileishmanial evaluation of 5m demonstrated 56.2% inhibition in liver and 61.1% inhibition in spleen parasite burden in infected Balb/c mice (12.5 mg kg-1, i.p.). In vitro pharmacokinetic study ascertained the stability of 5m in both simulated gastric fluid and simulated intestinal fluid. All the active compounds passed the PAINS filter and showed no toxicity in in silico predictions.
Version
No full-text in the repository
Citation
Seth A, Ghoshal A, Dewaker V et al (2022) Discovery of 2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one derivatives as possible antileishmanial agents. RSC Medicinal Chemistry. 13(6): 746-760.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article